Jump to content

COVID-19

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 36.76.229.147 (talk) at 12:25, 12 February 2020 (fix minor). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article is about the disease. For the virus, see 2019 novel coronavirus. For the outbreak, see 2019–20 Wuhan coronavirus outbreak.

COVID-19
Other namesNovel coronavirus pneumonia[1]
Symptoms
SpecialtyInfectious diseases, pulmonology, virology, epidemiology, emergency medicine Edit this on Wikidata
SymptomsFever, cough, shortness of breath
ComplicationsPneumonia, ARDS, kidney failure
CausesSARS-CoV-2
Diagnostic methodPCR testing
TreatmentSymptomatic and supportive

COVID-19 (COrona VIrus Disease 2019),[2] also known as 2019-nCoV acute respiratory disease, and novel coronavirus pneumonia ('NCP),[1] is an infectious disease caused by the 2019 novel coronavirus (SARS-CoV-2).[3][4] It was first detected during the 2019–20 Wuhan coronavirus outbreak.[5][6] It results in flu-like symptoms,[7][8] including fever, coughing, shortness of breath, pain in the muscles and tiredness. It may result in pneumonia, acute respiratory distress syndrome, sepsis and septic shock, and possible death. There is no specific treatment, with efforts typically to manage symptoms and support functioning.[7]

The most common method of spread is between people, generally airborne by respiratory droplets that people sneeze, cough, or exhale.[7] Symptoms generally begin 2 to 14 days after exposure.[9] Transmission can be limited by washing hands regularly, wearing surgical masks, and prompt diagnosis.[10][11][8]

The disease was first identified by health authorities in the city of Wuhan, capital of Hubei province in China, among patients who had developed pneumonia of no clear cause.[12] Amid rapid spread of the disease, the World Health Organization has since declared the 2019-20 Wuhan coronavirus outbreak to be a Public Health Emergency of International Concern (PHEIC), based on the impact the virus could have on poorer countries with weaker healthcare infrastructures.[13] Infections have been reported throughout the Western world and the Asia-Pacific, mostly of travelers originating in Mainland China, with local transmission also reported in Germany,[14] France,[15] Hong Kong,[16] Vietnam,[17] Thailand,[18] Singapore,[19] Japan,[18] South Korea,[20] and Australia.[21] The deaths have been reported in Mainland China, the Philippines,[22] and Hong Kong.[23] As of 11 February 2020, only Mainland China is listed as an area with known ongoing community transmission of SARS-CoV-2.[24]

Signs and symptoms

Those infected may either be asymptomatic or have mild to severe symptoms, like fever, cough, shortness of breath.[25][26][27] Diarrhea or upper respiratory symptoms (e.g. sneezing, runny nose, sore throat) are less frequent.[28] Cases can progress to severe pneumonia, multi-organ failure, and death.[5][29]

The incubation period is estimated at 2 to 10 days by the World Health Organization,[30] and 2 to 14 days by the US Centers for Disease Control and Prevention (CDC).[31] A study published in February by several dozen researchers in China, including the doctor responsible for discovering SARS, found evidence of the incubation period stretching to 24 days.[32]

Cause

Main article: 2019 novel coronavirus

The cause is the virus named SARS-CoV-2, [3] which is thought to have a zoonotic origin.[33]

The primary mode of transmission is human-to-human transmission via respiratory droplets that people sneeze, cough or exhale.[7]

Diagnosis

The WHO has published several testing protocols for the disease.[34][35] Testing uses real time reverse transcription-polymerase chain reaction (rRT-PCR).[36] The test can be done on respiratory or blood samples.[37] Results are generally available within a few hours to days.[38][39] Chinese scientists were able to isolate a strain of the coronavirus and publish the genetic sequence so that laboratories across the world could independently develop PCR tests to detect infection by the virus.[5][40][41][42][43]

Diagnostic guidelines released by Zhongnan Hospital of Wuhan University suggested methods for detecting infections based upon clinical features and epidemiological risk. These involved identifying patients who had at least two of the following symptoms in addition to a history of travel to Wuhan or contact with other infected patients: fever, imaging features of pneumonia, normal or reduced white blood cell count, or reduced lymphocyte count.[44]

Prevention

Global health organisations have published preventive measures to reduce the chances of infection. Recommendations are similar to those published for other coronaviruses and include: frequent washing of hands with soap and water; not touching the eyes, nose, or mouth with unwashed hands; and practicing good respiratory hygiene.[45][46]

Management

There are no known treatments for the disease. The WHO recommended volunteers take part in randomized controlled trials for testing the effectiveness and safety of potential treatments.[47]

Research into potential treatments for the disease were initiated in January 2020, and new therapies may take until 2021 to develop.[48] The Chinese Center for Disease Control and Prevention started testing existing pneumonia treatments in coronavirus-related pneumonia in late January.[49] There has also been examination of the RNA polymerase inhibitor remdesivir,[50][51][52][53] and interferon beta.[53]

In late January 2020, Chinese medical researchers expressed an intent to start clinical testing on remdesivir, chloroquine, and lopinavir/ritonavir, all of which seemed to have "fairly good inhibitory effects" on the virus at the cellular level in exploratory research.[54] On 5 February 2020, China started patenting use of remdesivir for the disease.[55][56][57]

The Russian Ministry of Health identified 3 medicines for adults that may help treat the disease, in late January 2020. Ribavirin, lopinavir/ritonavir and interferon beta-1b can be used to fight the coronavirus, according to them. These drugs are typically used to treat hepatitis C, HIV and multiple sclerosis respectively. The Russian Health Ministry offered descriptions and guidelines in how the treatments works, and in what quantities these recommendations should be prescribed for doctors in hospitals throughout Russia.[58] In February it was reported that China started testing Triazavirin, a 2014 Russian anti-viral drug, in the hope that it might be helpful in controlling the new coronavirus. Triazavirin was developed at Ural Federal University in Yekaterinburg, originally to combat H5N1. Due to similarities between the two infections, the researchers feel that it may be worth testing according to the reports. The drug is claimed to be effective against Rift Valley fever and the West Nile virus, as well as other viral infections.[59][60]

Epidemiology

Main article: 2019–20 Wuhan coronavirus outbreak

Overall mortality and morbidity rates due to infection are not well established; while the case fatality rate changes over time in the current outbreak, the proportion of infections that progress to diagnosable disease remains unclear.[61][62] However, preliminary research has yielded case fatality rate numbers between 2% and 3%,[63] and in January 2020 the WHO suggested that the case fatality rate was approximately 3%.[64] An unreviewed Imperial College preprint study among 55 fatal cases noted that early estimates of mortality may be too high as asymptomatic infections are missed. They estimated a mean infection fatality ratio (the mortality among infected) ranging from 0.8% when including asymptomatic carriers to 18% when including only symptomatic cases from Hubei province.[65]

As of 12 February 2020, 45,207 cases have been confirmed, 7,345 are severe (16%)[66] with 4,805 having recovered.[67]

Prognosis

Early data indicates that among the first 41 confirmed cases that were admitted to hospitals in Wuhan, 13 (32%) individuals required intensive care, and 6 (15%) individuals died.[28] Of those who died, many were in unsound health to begin with, exhibiting conditions like hypertension, diabetes, or cardiovascular disease that impaired their immune systems.[68]

In early cases that resulted in death, the median time of disease was found to be 14 days, with a total range from six to 41 days.[69]

Psychological

Psychological effects may be caused by feeling trapped under quarantine, travel restrictions and isolation.[70] At the end of January 2020, the National Health Commission of China published a national guideline of psychological crisis intervention for the disease, endorsing mental health care for people affected, close contacts, those isolated at home, families and friends of affected people, health care workers and the general public who need it.[71][72]

Naming

The World Health Organization on 11 February 2020 announced that "COVID-19" will be the official name of the disease. World Health Organization chief Tedros Adhanom Ghebreyesus said "co" stands for "corona", "vi" for "virus" and "d" for "disease", while "19" was for the year, as the outbreak was first identified on December 31. Tedros said the name had been chosen to avoid references to a specific geographical location, animal species or group of people in line with international recommendations for naming aimed at preventing stigmatisation.[73]

See also

References

  1. ^ a b "国家卫生健康委关于新型冠状病毒肺炎暂命名事宜的通知". 7 February 2020. Retrieved 9 February 2020.{{cite web}}: CS1 maint: url-status (link)
  2. ^ World Health Organization (11 February 2020). Novel Coronavirus (‎‎‎2019-nCoV)‎‎‎: situation report, 22 (PDF) (Report). World Health Organization.{{cite report}}: CS1 maint: date and year (link)
  3. ^ a b Gorbalenya, Alexander E. (11 February 2020). "Severe acute respiratory syndrome-related coronavirus – The species and its viruses, a statement of the Coronavirus Study Group". bioRxiv: 2020.02.07.937862. doi:10.1101/2020.02.07.937862.
  4. ^ "Coronavirus disease named Covid-19". BBC News. 11 February 2020. Retrieved 11 February 2020.
  5. ^ a b c Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, Zumla A, Petersen E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 Jan 14;91:264–266. doi:10.1016/j.ijid.2020.01.009. PMID 31953166.Open access icon
  6. ^ "Q&A on coronaviruses". World Health Organization (WHO). Archived from the original on 20 January 2020. Retrieved 27 January 2020.
  7. ^ a b c d "Q & A on novel coronavirus". European Centre for Disease Prevention and Control. Retrieved 11 February 2020.
  8. ^ a b Health, Australian Government Department of (21 January 2020). "Novel coronavirus (2019-nCoV)". Australian Government Department of Health. Retrieved 11 February 2020.
  9. ^ "Symptoms of Novel Coronavirus (2019-nCoV) | CDC". www.cdc.gov. 10 February 2020. Retrieved 11 February 2020.
  10. ^ "Do you need to wear a mask to protect yourself from the coronavirus?". The Feed. Retrieved 11 February 2020.
  11. ^ "MOH | Updates on 2019 Novel Coronavirus (2019-nCoV) Local Situation". www.moh.gov.sg. Retrieved 11 February 2020.
  12. ^ "Disease background of 2019-nCoV". European Centre for Disease Prevention and Control. Retrieved 11 February 2020.
  13. ^ "Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)". www.who.int. Retrieved 11 February 2020.
  14. ^ Boseley, Sarah (28 January 2020). "Germany confirms first human coronavirus transmission in Europe". The Guardian. ISSN 0261-3077. Retrieved 11 February 2020.
  15. ^ Specia, Megan; Méheut, Constant (10 February 2020). "U.K. Declares Coronavirus 'Imminent Threat' as Europe Scrambles". The New York Times. ISSN 0362-4331. Retrieved 11 February 2020.
  16. ^ hermesauto (11 February 2020). "Coronavirus: Hong Kong to evacuate residential building after suspected environmental transmission". The Straits Times. Retrieved 11 February 2020.
  17. ^ "The Coronavirus Is Now Infecting People Who Haven't Traveled to China". Wired. ISSN 1059-1028. Retrieved 11 February 2020.
  18. ^ a b Feb 04, Lisa Schnirring | News Editor | CIDRAP News |; 2020. "nCoV total tops 20,000 as officials probe spread from nations outside of China". CIDRAP. Retrieved 11 February 2020. {{cite web}}: |first= has generic name (help); |last2= has numeric name (help)CS1 maint: numeric names: authors list (link)
  19. ^ "Singapore announces first local coronavirus transmissions". France 24. 4 February 2020. Retrieved 11 February 2020.
  20. ^ "South Korea reports first local human-to-human transmission of coronavirus | The Star Online". www.thestar.com.my. Retrieved 11 February 2020.
  21. ^ Hundreds of evacuees to be held on bases in California; Hong Kong and Taiwan restrict travel from mainland China - The Washington Post
  22. ^ Ramzy, Austin; May, Tiffany (2 February 2020). "Philippines Reports First Coronavirus Death Outside China". The New York Times. ISSN 0362-4331. Retrieved 11 February 2020.
  23. ^ Hui, Mary. "Hong Kong has reported its first coronavirus death". Quartz. Retrieved 11 February 2020.
  24. ^ "Areas with presumed ongoing community transmission of 2019-nCoV". European Centre for Disease Prevention and Control. Retrieved 11 February 2020.
  25. ^ Chen, Nanshan; Zhou, Min; Dong, Xuan; Qu, Jieming; Gong, Fengyun; Han, Yang; Qiu, Yang; Wang, Jingli; Liu, Ying; Wei, Yuan; Xia, Jia'an (30 January 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". The Lancet. 0. doi:10.1016/S0140-6736(20)30211-7. ISSN 0140-6736. PMID 32007143.
  26. ^ Hessen, Margaret Trexler (27 January 2020). "Novel Coronavirus Information Center: Expert guidance and commentary". Elsevier Connect. Archived from the original on 30 January 2020. Retrieved 31 January 2020.
  27. ^ "Coronavirus About Symptoms and Diagnosis". Centers for Disease Control and Prevention. United States. 30 January 2020. Archived from the original on 30 January 2020. Retrieved 1 February 2020.
  28. ^ a b Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun (24 January 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. doi:10.1016/S0140-6736(20)30183-5. ISSN 0140-6736. PMID 31986264.
  29. ^ "Q&A on coronaviruses". who.int. Archived from the original on 20 January 2020. Retrieved 27 January 2020.
  30. ^ World Health Organization (2020). Novel Coronavirus (‎‎‎2019-nCoV)‎‎‎: situation report, 6 (PDF) (Report). World Health Organization.
  31. ^ "Symptoms of Novel Coronavirus (2019-nCoV)". Centers for Disease Control and Prevention (CDC). 31 January 2020. Archived from the original on 30 January 2020. Retrieved 2 February 2020.
  32. ^ hermesauto (11 February 2020). "Coronavirus: New study finds incubation period of up to 24 days". The Straits Times. Retrieved 11 February 2020.
  33. ^ Zhou, Peng; Yang, Xing-Lou; Wang, Xian-Guang; Hu, Ben; Zhang, Lei; Zhang, Wei; Si, Hao-Rui; Zhu, Yan; Li, Bei; Huang, Chao-Lin; Chen, Hui-Dong; Chen, Jing; Luo, Yun; Guo, Hua; Jiang, Ren-Di; Liu, Mei-Qin; Chen, Ying; Shen, Xu-Rui; Wang, Xi; Zheng, Xiao-Shuang; Zhao, Kai; Chen, Quan-Jiao; Deng, Fei; Liu, Lin-Lin; Yan, Bing; Zhan, Fa-Xian; Wang, Yan-Yi; Xiao, Gengfu; Shi, Zheng-Li (23 January 2020). "Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin". bioRxiv: 2020.01.22.914952. doi:10.1101/2020.01.22.914952. Archived from the original on 24 January 2020. Retrieved 5 February 2020.
  34. ^ Schirring, Lisa; 2020 (16 January 2020). "Japan has 1st novel coronavirus case; China reports another death". CIDRAP. Archived from the original on 20 January 2020. Retrieved 16 January 2020. {{cite web}}: |last2= has numeric name (help)
  35. ^ "Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases: Interim guidance". World Health Organization. Archived from the original on 20 January 2020. Retrieved 28 January 2020.
  36. ^ "2019 Novel Coronavirus (2019-nCoV) Situation Summary". Centers for Disease Control and Prevention. 30 January 2020. Archived from the original on 26 January 2020. Retrieved 30 January 2020.
  37. ^ "Real-Time RT-PCR Panel for Detection 2019-nCoV". Centers for Disease Control and Prevention. 29 January 2020. Archived from the original on 30 January 2020. Retrieved 1 February 2020.
  38. ^ Brueck, Hilary (30 January 2020). "There's only one way to know if you have the coronavirus, and it involves machines full of spit and mucus". Business Insider. Archived from the original on 1 February 2020. Retrieved 1 February 2020.
  39. ^ "Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (2019-nCoV) Testing in Europe". GlobeNewswire News Room. 30 January 2020. Archived from the original on 31 January 2020. Retrieved 1 February 2020.
  40. ^ "Undiagnosed pneumonia – China (HU) (01): wildlife sales, market closed, RFI Archive Number: 20200102.6866757". Pro-MED-mail. International Society for Infectious Diseases. Archived from the original on 22 January 2020. Retrieved 13 January 2020.
  41. ^ Cohen, Jon; Normile, Dennis (17 January 2020). "New SARS-like virus in China triggers alarm" (PDF). Science. 367 (6475): 234–235. doi:10.1126/science.367.6475.234. ISSN 0036-8075. PMID 31949058.
  42. ^ Parry, Jane (January 2020). "China coronavirus: cases surge as official admits human to human transmission". British Medical Journal. 368: m236. doi:10.1136/bmj.m236. ISSN 1756-1833. PMID 31959587.
  43. ^ Voytko, Lisette. "WHO Declares Coronavirus A Global Health Emergency, Praises China's 'Extraordinary Measures'". Forbes. Archived from the original on 1 February 2020. Retrieved 1 February 2020.
  44. ^ Jin, Ying-Hui; Cai, Lin; Cheng, Zhen-Shun; Cheng, Hong; Deng, Tong; Fan, Yi-Pin; Fang, Cheng; Huang, Di; Huang, Lu-Qi; Huang, Qiao; Han, Yong (6 February 2020). "A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)". Military Medical Research. 7 (1): 4. doi:10.1186/s40779-020-0233-6. ISSN 2054-9369. PMID 32029004.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  45. ^ "Coronavirus | About | Prevention and Treatment | CDC". www.cdc.gov. 3 February 2020. Retrieved 10 February 2020.
  46. ^ "Advice for public". www.who.int. Retrieved 10 February 2020.
  47. ^ Nebehay, Stephanie; Kelland, Kate; Liu, Roxanne (5 February 2020). "WHO: 'no known effective' treatments for new coronavirus". Thomson Reuters. Archived from the original on 5 February 2020. Retrieved 5 February 2020.
  48. ^ Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends. 28 Jan 2020. doi:10.5582/bst.2020.01020
  49. ^ "China CDC developing novel coronavirus vaccine". Xinhua. 26 January 2020. Archived from the original on 26 January 2020. Retrieved 28 January 2020.
  50. ^ Holshue, Michelle L.; DeBolt, Chas; Lindquist, Scott; Lofy, Kathy H.; Wiesman, John; Bruce, Hollianne; Spitters, Christopher; Ericson, Keith; Wilkerson, Sara; Tural, Ahmet; Diaz, George (31 January 2020). "First Case of 2019 Novel Coronavirus in the United States". New England Journal of Medicine: NEJMoa2001191. doi:10.1056/NEJMoa2001191. ISSN 0028-4793. PMID 32004427.
  51. ^ "Anti-novel coronavirus drug under clinical trial: official". Xinhuanet. Archived from the original on 3 February 2020. Retrieved 3 February 2020.
  52. ^ Xu, Zhijian; Peng, Cheng; Shi, Yulong; Zhu, Zhengdan; Mu, Kaijie; Wang, Xiaoyu; Zhu, Weiliang (28 January 2020). "Nelfinavir was predicted to be a potential inhibitor of 2019 nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation". bioRxiv: 2020.01.27.921627. doi:10.1101/2020.01.27.921627 – via www.biorxiv.org.
  53. ^ a b Paules, Catharine I.; Marston, Hilary D.; Fauci, Anthony S. (23 January 2020). "Coronavirus Infections—More Than Just the Common Cold". JAMA. doi:10.1001/jama.2020.0757. PMID 31971553.
  54. ^ Wang M, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res (2020). doi:10.1038/s41422-020-0282-0
  55. ^ "China Applies for Patent for Potential Coronavirus Drug". Time. Archived from the original on 6 February 2020. Retrieved 5 February 2020.
  56. ^ Feb 5, Reuters |; 2020 (5 February 2020). "China lab seeks patent on use of Gilead's coronavirus treatment". Physician's Weekly. Archived from the original on 5 February 2020. Retrieved 5 February 2020. {{cite web}}: |first= has generic name (help); |last2= has numeric name (help)CS1 maint: numeric names: authors list (link)
  57. ^ "我国学者在抗2019新型冠状病毒药物筛选方面取得重要进展". whiov.ac.cn. Archived from the original on 5 February 2020. Retrieved 5 February 2020.
  58. ^ "Russia's Ministry of Health names three drugs that can treat new Chinese coronavirus". Retrieved 10 February 2020.
  59. ^ "China tests Russian anti-viral drug which might treat coronavirus as Moscow warns of possible 'mass outbreak'". Retrieved 11 February 2020.
  60. ^ "China Tests Russian Antiviral Drug Which Might Treat Coronavirus As Moscow Warns Of Possible 'Mass Outbreak'". Retrieved 11 February 2020.
  61. ^ "Limited data on coronavirus may be skewing assumptions about severity". STAT. 30 January 2020. Archived from the original on 1 February 2020. Retrieved 1 February 2020.
  62. ^ Sparrow, Annie. "How China's Coronavirus Is Spreading—and How to Stop It". Foreign Policy. Archived from the original on 31 January 2020. Retrieved 2 February 2020.
  63. ^ "Wuhan Coronavirus Death Rate - Worldometer". www.worldometers.info. Archived from the original on 31 January 2020. Retrieved 2 February 2020.
  64. ^ "WHOが"致死率３％程度" 専門家「今後 注意が必要」". NHK. 24 January 2020. Archived from the original on 26 January 2020. Retrieved 3 February 2020.
  65. ^ "Report 4: Severity of 2019-novel coronavirus (nCoV)" (PDF).
  66. ^ "Coronavirus cases". Worldometers. Archived from the original on 31 January 2020. Retrieved 5 February 2020.
  67. ^ "Tracking coronavirus: Map, data and timeline". BNO News. 8 February 2020. Archived from the original on 28 January 2020. Retrieved 8 February 2020.
  68. ^ "WHO Director-General's statement on the advice of the IHR Emergency Committee on Novel Coronavirus". who.int.
  69. ^ Wang, Weier; Tang, Jianming; Wei, Fangqiang (2020). "Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China". Journal of Medical Virology. doi:10.1002/jmv.25689. PMID 31994742.
  70. ^ "Coronavirus: The psychological effects of quarantining a city". The British Medical Journal. 24 January 2020. Retrieved 10 February 2020.{{cite web}}: CS1 maint: url-status (link)
  71. ^ Xiang, Yu-Tao; Yang, Yuan; Li, Wen; Zhang, Ling; Zhang, Qinge; Cheung, Teris; Ng, Chee H (4 February 2020). "Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed". The Lancet Psychiatry: S2215036620300468. doi:10.1016/S2215-0366(20)30046-8.
  72. ^ Kang, Lijun; Li, Yi; Hu, Shaohua; Chen, Min; Yang, Can; Yang, Bing Xiang; Wang, Ying; Hu, Jianbo; Lai, Jianbo; Ma, Xiancang; Chen, Jun (5 February 2020). "The mental health of medical workers in Wuhan, China dealing with the 2019 novel coronavirus". The Lancet Psychiatry: S221503662030047X. doi:10.1016/S2215-0366(20)30047-X.
  73. ^ "Novel coronavirus named 'Covid-19': WHO". TODAYonline. Retrieved 11 February 2020.


Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19&oldid=940416309"